Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5 ‐fluorouracil and leucovorin

ConclusionsPrevious conventional irinotecan treatment does not compromise the efficacy of subsequent nal-IRI+5-FU/LV treatment in mPDAC patients.

Source: Journal of Hepato-Biliary-Pancreatic Sciences - February 20, 2022 Category: Gastroenterology Authors: Tai ‐Jan Chiu, Shih‐Hung Yang, Sz‐Chi Chiu, Shun‐Wen Hsueh, Nai‐Jung Chiang, Chung‐Pin Li, Li‐Yuan Bai, Fu‐Ming Cheng, Shih‐Chang Chuang, Yan‐Shen Shan, De‐Chuan Chan, Li‐Tzong Chen, Chia‐Jui Yen, Cheng‐Ming Peng, Tags: ORIGINAL ARTICLE Source Type: research